In conclusion, a risk model constructed by 6 hypoxia-driven genes (WT1, HOXA2, HOXC6, MMP9, SHOX2 and MYOD1) provide valuable clinical utility for the prognostic prediction of glioma patients. Here, SHOX2 is linked to central nervous system cancer.